Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-20

Clinical Trial Update: NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial of Natural Tocotrienol for ischemic stroke and TIA completed (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Natural Tocotrienol

Snippet

Sponsor: Andrew Slivka | Conditions: Ischemic Stroke, Transient Ischemic Attack (TIA) | Phase 1, Phase 2 | Status: COMPLETED